Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,631 | N/A | 4,257 | 4,455 | 4,642 |
| Marketable Securities | 2,411 | N/A | N/A | N/A | N/A |
| Other current assets | 79 | 0 | 2,630 | 2,375 | 3,265 |
| TOTAL | $6,121 | $N/A | $6,887 | $6,830 | $7,907 |
| Non-Current Assets | |||||
| PPE Net | 2 | N/A | N/A | N/A | N/A |
| Intangibles | 380 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 382 | 382 | 382 |
| TOTAL | $382 | $N/A | $382 | $382 | $382 |
| Total Assets | $6,503 | $N/A | $7,269 | $7,212 | $8,289 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 254 | 0 | 244 | 232 | 0 |
| TOTAL | $254 | $N/A | $244 | $232 | $200 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,637 | 0 | 0 | 0 | 0 |
| TOTAL | $2,637 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,891 | $N/A | $244 | $232 | $200 |
| Shareholders' Equity | |||||
| Common Shares | 13,182 | N/A | N/A | N/A | N/A |
| Retained earnings | -155,605 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 20 | 0 | 7,025 | 6,980 | 8,089 |
| TOTAL | $3,612 | $N/A | $7,025 | $6,980 | $8,089 |
| Total Liabilities And Equity | $6,503 | $0 | $7,269 | $7,212 | $8,289 |